Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial

Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial

Von Hippel–Lindau disease (VHL) is a hereditary disorder associated with malignant tumors including clear cell renal cell carcinoma (ccRCC). Partial nephrectomy is complicated by multilocular tumor occurrence and a high recurrence rate. The aim of this study was to evaluate the potential of stereota...

Full description

Bibliographic Details
Main Authors: Simon Kirste, Alexander Rühle, Stefan Zschiedrich, Wolfgang Schultze-Seemann, Cordula A. Jilg, Elke Neumann-Haefelin, Simon S. Lo, Anca-Ligia Grosu, Emily Kim
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
stereotactic body radiotherapy
SBRT
stereotactic ablative radiotherapy
SABR
renal cell carcinoma
von Hippel–Lindau disease
Online Access:https://www.mdpi.com/2072-6694/14/20/5069

Internet

https://www.mdpi.com/2072-6694/14/20/5069

Similar Items